Ref.: BL-RE-092838Manufacturer ref.: EH4RBX5 5 x 96 tests
€2,950.00 excl. VAT
Human 4-1BB Ligand quantitates human 4-1BB Ligand in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human 4-1BB Ligand.
Accession number
Ligand 4 1 BB ; 4 1 BBL ; ligand 41 BB ; ligand 4-1 BB ; 41 BBL ; 4-1 BBL ; 4-1 BB-L ; AI848817 ; ligand CD 137 ; CD 137 L ; ligand CD137 ; CD137L ; Cd157l ; CDw137L ; molécule de costimulation ; homologue de souris 4-1 BB-L ; Ly63l ; ligand récepteur 4-1 BB ; TNFRSF9 ; Tnfsf9 ; TNLG5A ; membre de la superfamille de facteur de nécrose tumorale (ligand) 9 ; superfamille de facteur de nécrose tumorale (ligand), membre 9 ; ligand du facteur de nécrose tumorale 5 A ; membre de la superfamille de ligand du facteur de nécrose tumorale 9 ; membre de la superfamille du facteur de nécrose tumorale 9
Dose range
0.2 to 50 ng/ml
Sensitivity of the dosage
0.2 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen
Human 4-1BB Ligand quantitates human 4-1BB Ligand in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human 4-1BB Ligand.
Human 4-1BB Ligand quantitates human 4-1BB Ligand in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human 4-1BB Ligand.
CD137 ligand (CD137L) is a II membrane protein and is part of the TNF superfamily. CD137L is a co-stimulatory molecule that is expressed on antigen cells (DC, monocytes/macrophages, B cells) and is regulated at the time of activation. Its receptor, CD137/4-1BB, is found on a variety of cells, including inflamed endothelial cells, where its expression improves the extravasation of monocytes expressing CD137L. Activated T cells also express CD137 and engagement with CD137L improves T cell proliferation, secretion of IL-2, survival and cytotoxic activity. CD137L is also expressed on a majority of B cell lymphoma, including mantle cell lymphoma, follicular lymphoma, and large B cell lymphoma (but it does not express on Hodgkin's lymphoma or T cell lymphoma). CD137L is also expressed in cell lines of carcinoma, and is considered to be involved in tumour T-cell interactions.
Sensitivity
Sensitivity of dosage: 0.2 ng/ml.
Measurement range
Dose range: 0.2 to 50 ng/ml.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Target
Target: 4-1 BBL (CD137L).
Samples
Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).
Technical specifications
General
Brand
Invitrogen
Supplier ref. (Fisher Scientific)
17165279
Specifications
Accession number
Ligand 4 1 BB; 4 1 BBL; ligand 41 BB; ligand 4-1 BB; 41 BBL; 4-1 BBL; 4-1 BB-L; AI848817; ligand CD 137; CD 137 L; CD137 ligand; CD137L; Cd157l; CDw137L; costimulation molecule; mouse homologous 4-1 BB-L; Ly63l; receptor ligand 4-1 BB; TNFRSF9; Tnfsf9; TNLG5A; member of the